AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Short Interest Up 34.3% in January

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totaling 1,643,942 shares, a growth of 34.3% from the December 31st total of 1,224,007 shares. Currently, 7.1% of the company’s stock are short sold. Based on an average daily trading volume, of 611,427 shares, the days-to-cover ratio is presently 2.7 days. Based on an average daily trading volume, of 611,427 shares, the days-to-cover ratio is presently 2.7 days. Currently, 7.1% of the company’s stock are short sold.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Creative Financial Designs Inc. ADV increased its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 2.5% during the third quarter. Creative Financial Designs Inc. ADV now owns 224,292 shares of the company’s stock valued at $3,571,000 after acquiring an additional 5,487 shares in the last quarter. PMV Capital Advisers LLC boosted its stake in AGF U.S. Market Neutral Anti-Beta Fund by 35.5% during the 3rd quarter. PMV Capital Advisers LLC now owns 204,763 shares of the company’s stock valued at $3,260,000 after purchasing an additional 53,603 shares during the last quarter. L.M. Kohn & Company bought a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund in the 2nd quarter worth $570,000. Worth Asset Management LLC purchased a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund in the fourth quarter worth $364,000. Finally, Ethos Financial Group LLC lifted its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 24.7% during the second quarter. Ethos Financial Group LLC now owns 25,229 shares of the company’s stock valued at $446,000 after purchasing an additional 5,004 shares in the last quarter.

AGF U.S. Market Neutral Anti-Beta Fund Stock Up 0.5%

Shares of NYSEARCA BTAL traded up $0.08 during trading on Tuesday, reaching $14.17. The company had a trading volume of 390,623 shares, compared to its average volume of 601,562. AGF U.S. Market Neutral Anti-Beta Fund has a 12-month low of $13.66 and a 12-month high of $22.10. The business’s 50-day moving average is $14.31 and its 200 day moving average is $15.33. The stock has a market cap of $328.63 million, a PE ratio of 17.67 and a beta of -0.66.

AGF U.S. Market Neutral Anti-Beta Fund Announces Dividend

The company also recently disclosed an annual dividend, which was paid on Friday, January 2nd. Shareholders of record on Tuesday, December 30th were paid a dividend of $0.3579 per share. This represents a yield of 249.0%. The ex-dividend date was Tuesday, December 30th.

AGF U.S. Market Neutral Anti-Beta Fund Company Profile

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.